Basics Olema Pharmaceuticals, Inc. IPO Date: November 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $568.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.50 | 3.94% Avg Daily Range (30 D): $0.32 | 3.60% Avg Daily Range (90 D): $0.24 | 3.71% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): 1.21M Avg Daily Volume (90 D): .82M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 88 Institutional Trades Total Inst.Trades: 764 Avg Inst. Trade: $1.72M Avg Inst. Trade (30 D): $1.52M Avg Inst. Trade (90 D): $1.64M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.04M Avg Closing Trade (30 D): $1.27M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 165.9K     News Oct 18, 2025 @ 7:00 AM Olema Oncology Announces New Data from the Phase 1... Source: Olema Oncology May 28, 2025 @ 11:00 AM Olema Oncology Announces Palazestrant Dose Selecti... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Apr 25, 2025 @ 5:00 PM Olema Oncology Announces New Preclinical Data for ... Source: N/A Jan 3, 2025 @ 9:30 PM Olema Oncology Reports Inducement Grants Under Nas... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.87 $-.51 $-.36 Diluted EPS $-1.87 $-.51 $-.36 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -142.3M $ -43.78M $ -30.39M Operating Income / Loss $ -157.13M $ -47.86M $ -34.87M Cost of Revenue $ $ $ Net Cash Flow $ 35.58M $ 1.83M $ -88.84M PE Ratio